Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments
- PMID:15203786
- DOI: 10.1080/14622200410001696501
Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments
Abstract
The present study examined several pharmacological and behavioral treatments designed to promote extinction of the responses to rewarding cigarette smoke cues. Pharmacological treatments comprised nicotine skin patches (21 mg/24 hr) and the nicotinic acetylcholine receptor antagonist mecamylamine (10 mg/day), administered separately or in combination. Behavioral manipulations included switching to denicotinized cigarettes, to cigarettes having different menthol flavor, or to ventilated-filter (low tar and nicotine) cigarettes. Smokers were assigned to the various treatments for 2 weeks before they quit smoking. During weekly test sessions, subjects rated the rewarding effects of their usual brands of cigarettes or cigarettes with different menthol content (mentholated vs. nonmentholated). Over the 2-week treatment period, all pharmacological treatments reduced ratings of reward for the usual-brand test cigarettes. Switching to smoking denicotinized cigarettes for 2 weeks similarly decreased rewarding effects of the usual-brand test cigarettes. Subjects also strongly preferred cigarettes with the same menthol content to which they were accustomed. However, manipulating the menthol content of the cigarettes smoked during the 2 weeks of treatment had different effects, depending on whether smokers habitually smoked mentholated or nonmentholated cigarettes. For menthol smokers, removal of the menthol cue hampered extinction of reward ratings for the usual-brand (mentholated) test cigarette. For nonmenthol smokers, addition of the menthol cue did not affect the progress of extinction of nonmenthol smoke cues. These findings demonstrate the importance of sensory cues in determining subjective reward and show that the reward value of these cues can be altered by removal of nicotine from tobacco or by pharmacological manipulations that interfere with the reinforcing effects of nicotine.
Similar articles
- Precessation treatment with nicotine skin patch facilitates smoking cessation.Rose JE, Behm FM, Westman EC, Kukovich P.Rose JE, et al.Nicotine Tob Res. 2006 Feb;8(1):89-101. doi: 10.1080/14622200500431866.Nicotine Tob Res. 2006.PMID:16497603Clinical Trial.
- Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.Rezaishiraz H, et al.Nicotine Tob Res. 2007 Nov;9(11):1139-46. doi: 10.1080/14622200701684172.Nicotine Tob Res. 2007.PMID:17978987Clinical Trial.
- Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.Rose JE, Behm FM, Ramsey C, Ritchie JC Jr.Rose JE, et al.Nicotine Tob Res. 2001 Nov;3(4):383-90. doi: 10.1080/14622200110087277.Nicotine Tob Res. 2001.PMID:11694206Clinical Trial.
- Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.Le Houezec J.Le Houezec J.Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9.Int J Tuberc Lung Dis. 2003.PMID:12971663Review.
- The relevance and treatment of cue-induced cravings in tobacco dependence.Ferguson SG, Shiffman S.Ferguson SG, et al.J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20.J Subst Abuse Treat. 2009.PMID:18715743Review.
Cited by
- Withdrawal: Expanding a Key Addiction Construct.Piper ME.Piper ME.Nicotine Tob Res. 2015 Dec;17(12):1405-15. doi: 10.1093/ntr/ntv048. Epub 2015 Mar 5.Nicotine Tob Res. 2015.PMID:25744958Free PMC article.Review.
- Agonist replacement for stimulant dependence: a review of clinical research.Stoops WW, Rush CR.Stoops WW, et al.Curr Pharm Des. 2013;19(40):7026-35. doi: 10.2174/138161281940131209142843.Curr Pharm Des. 2013.PMID:23574440Free PMC article.Review.
- Sensory properties of menthol and smoking topography.Lawrence D, Cadman B, Hoffman AC.Lawrence D, et al.Tob Induc Dis. 2011 May 23;9 Suppl 1(Suppl 1):S3. doi: 10.1186/1617-9625-9-S1-S3.Tob Induc Dis. 2011.PMID:21624149Free PMC article.
- Smoking withdrawal in smokers with and without posttraumatic stress disorder.Dedert EA, Calhoun PS, Harper LA, Dutton CE, McClernon FJ, Beckham JC.Dedert EA, et al.Nicotine Tob Res. 2012 Mar;14(3):372-6. doi: 10.1093/ntr/ntr142. Epub 2011 Oct 24.Nicotine Tob Res. 2012.PMID:22025546Free PMC article.
- Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST.Arger CA, et al.Exp Clin Psychopharmacol. 2017 Dec;25(6):473-478. doi: 10.1037/pha0000145.Exp Clin Psychopharmacol. 2017.PMID:29251976Free PMC article.Clinical Trial.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical